Bahadır Şahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bahadır Şahin has a total of 535 co-authors. Here are the top co-authors by number of shared publications:
- Ashok Agarwal
Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA ; Cleveland Clinic, Cleveland, OH, USA
15 shared publications - Germar-Michael Pinggera
Medical University Innsbruck
12 shared publications - Rupin Shah
Division of Andrology, Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India
12 shared publications - Taymour Mostafa
Cairo University
11 shared publications - Eric Chung
Department of Urology, Department of Urology, Associate Professor, Princess Alexandra Hospital , Brisbane, 4102
10 shared publications - Hiva Alipour
Aalborg University
10 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
GAF Survey on the Management of Hypogonadism in Men with Concomitant Varicocele: Gaps between Real-World Practice and Current Guidelines
Russo GI, et al. World J Mens Health. 2026 ;44:e86. https://doi.org/10.5534/wjmh.260152
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessGAF Survey on the Management of Hypogonadism in Men with Concomitant Varicocele: Gaps between Real-World Practice and Current Guidelines
Russo GI, et al. World J Mens Health. 2026 ;44:e86. https://doi.org/10.5534/wjmh.260152
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
The Global Andrology Forum: A Catalyst for Advancing Research Productivity in Andrology
Mahmutoglu AM, et al. World J Mens Health. 2026 ;44:e70. https://doi.org/10.5534/wjmh.260092
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessThe Global Andrology Forum: A Catalyst for Advancing Research Productivity in Andrology
Mahmutoglu AM, et al. World J Mens Health. 2026 ;44:e70. https://doi.org/10.5534/wjmh.260092
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
The Role of Digital Communication Tools in Enhancing Collaboration and Research Productivity: The Global Andrology Forum Model
Metin Mahmutoglu A, et al. World J Mens Health. 2026 ;44:e57. https://doi.org/10.5534/wjmh.260074
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessThe Role of Digital Communication Tools in Enhancing Collaboration and Research Productivity: The Global Andrology Forum Model
Metin Mahmutoglu A, et al. World J Mens Health. 2026 ;44:e57. https://doi.org/10.5534/wjmh.260074
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Effects of Low-Intensity Shock Wave Therapy on Erectile Function and Penile Vascular Parameters in Men with Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
This systematic review and meta-analysis of randomized controlled trials evaluated the effects of low-intensity shock wave therapy (LiSWT) on erectile function (EF) and penile vascular parameters in men with erectile dysfunction (ED), compared with controls receiving sham or no treatment. A systematic search of Scopus, PubMed, and Cochrane databases identified studies assessing LiSWT in men with ED. Primary outcomes were changes in the International Index of Erectile Function (IIEF)-5 and the IIEF-EF domain scores. Secondary outcomes included erection hardness score (EHS), sexual encounter profile (SEP) diary Q2 and Q3, global assessment question (GAQ) scores, and penile Doppler ultrasound parameters-peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI). Changes from baseline to the end of follow-up were compared between LiSWT and control groups. Of 527 retrieved articles, 12 met inclusion criteria. Pooled analysis demonstrated significantly greater improvements in the LiSWT group for IIEF-5 (standardized mean difference [SMD], 1.19; 95% confidence interval [CI], 0.47-1.91; p=0.001) and IIEF-EF (SMD, 1.24; 95% CI, 1.02-1.45; p<0.001) scores compared with controls. No significant differences were found for EHS (p=0.698), SEP-Q2 (p=0.934), SEP-Q3 (p=0.985), GAQ (p=0.993), and penile Doppler ultrasound parameters, including PSV (p=0.855), EDV (p=0.995), or RI (p=0.818). LiSWT provides modest improvements in IIEF scores but fails to produce significant changes in other functional or vascular parameters. These findings suggest that while LiSWT may offer some benefit, the clinical relevance is limited for most patients. Current evidence does not support its routine inclusion in ED treatment algorithms. Future research should focus on identifying patient subgroups most likely to experience significant and sustained improvements from this therapy.
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessEffects of Low-Intensity Shock Wave Therapy on Erectile Function and Penile Vascular Parameters in Men with Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
This systematic review and meta-analysis of randomized controlled trials evaluated the effects of low-intensity shock wave therapy (LiSWT) on erectile function (EF) and penile vascular parameters in men with erectile dysfunction (ED), compared with controls receiving sham or no treatment. A systematic search of Scopus, PubMed, and Cochrane databases identified studies assessing LiSWT in men with ED. Primary outcomes were changes in the International Index of Erectile Function (IIEF)-5 and the IIEF-EF domain scores. Secondary outcomes included erection hardness score (EHS), sexual encounter profile (SEP) diary Q2 and Q3, global assessment question (GAQ) scores, and penile Doppler ultrasound parameters-peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI). Changes from baseline to the end of follow-up were compared between LiSWT and control groups. Of 527 retrieved articles, 12 met inclusion criteria. Pooled analysis demonstrated significantly greater improvements in the LiSWT group for IIEF-5 (standardized mean difference [SMD], 1.19; 95% confidence interval [CI], 0.47-1.91; p=0.001) and IIEF-EF (SMD, 1.24; 95% CI, 1.02-1.45; p<0.001) scores compared with controls. No significant differences were found for EHS (p=0.698), SEP-Q2 (p=0.934), SEP-Q3 (p=0.985), GAQ (p=0.993), and penile Doppler ultrasound parameters, including PSV (p=0.855), EDV (p=0.995), or RI (p=0.818). LiSWT provides modest improvements in IIEF scores but fails to produce significant changes in other functional or vascular parameters. These findings suggest that while LiSWT may offer some benefit, the clinical relevance is limited for most patients. Current evidence does not support its routine inclusion in ED treatment algorithms. Future research should focus on identifying patient subgroups most likely to experience significant and sustained improvements from this therapy.
- Top Cited PapersOpen Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility
Agarwal A, et al. World J Mens Health. 2026 Jan;44:e3. https://doi.org/10.5534/wjmh.250290
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Top Cited PapersOpen AccessGlobal Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility
Agarwal A, et al. World J Mens Health. 2026 Jan;44:e3. https://doi.org/10.5534/wjmh.250290
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (3) , 608-633
The Global State of Contemporary Andrology Practice: A Comprehensive Analysis of Clinical Practice, Training Pathways, and Emerging Challenges
Shah R, et al. World J Mens Health. 2025 Jun;43:e41. https://doi.org/10.5534/wjmh.250039
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (3) , 608-633
Open AccessThe Global State of Contemporary Andrology Practice: A Comprehensive Analysis of Clinical Practice, Training Pathways, and Emerging Challenges
Shah R, et al. World J Mens Health. 2025 Jun;43:e41. https://doi.org/10.5534/wjmh.250039
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (2) , 253-267
Development of a Training Program for Meta-Analytical Research: A Novel Approach to Minimizing Errors in Medical Systematic Reviews and Meta-Analyses
Palani A, et al. World J Mens Health. 2025 Jun;43:e37. https://doi.org/10.5534/wjmh.250008
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (2) , 253-267
Open AccessDevelopment of a Training Program for Meta-Analytical Research: A Novel Approach to Minimizing Errors in Medical Systematic Reviews and Meta-Analyses
Palani A, et al. World J Mens Health. 2025 Jun;43:e37. https://doi.org/10.5534/wjmh.250008
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (2) , 370-387
Mapping the Scientometric Landscape of Andrology: Trends, Gaps, and Future Directions in Male Reproductive Health: A Scoping Review
Mahmutoglu AM, et al. World J Mens Health. 2025 Apr;43:e22. https://doi.org/10.5534/wjmh.250006
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (2) , 370-387
Open AccessMapping the Scientometric Landscape of Andrology: Trends, Gaps, and Future Directions in Male Reproductive Health: A Scoping Review
Mahmutoglu AM, et al. World J Mens Health. 2025 Apr;43:e22. https://doi.org/10.5534/wjmh.250006
- 31 July 2025
- Published by Wiley in BJU International
Chatbots in urology: accuracy, calibration, and comprehensibility; is DeepSeek taking over the throne?
Objective: To evaluate widely used chatbots’ accuracy, calibration error, readability, and understandability with objective measurements by 35 questions derived from urology in‐service examinations, as the integration of large language models (LLMs) into healthcare has gained increasing attention, raising questions about their applications and limitations.Materials and Methods: A total of 35 European Board of Urology questions were asked to five LLMs with a standardised prompt that was systematically designed and used across all models: ChatGPT‐4o, DeepSeek‐R1, Gemini, Grok‐2, and Claude 3.5. Accuracy was calculated by Cohen's kappa for all models. Readability was assessed by Flesch Reading Ease, Gunning Fog, Coleman–Liau, Simple Measure of Gobbledygook, and Automated Readability Index, while understandability was determined by scores of residents’ ratings by a Likert scale.Results: The models and answer key were in substantial agreement with a Fleiss’ kappa of 0.701, and Cronbach's alpha of 0.914. For accuracy, Cohen's kappa was 0.767 for ChatGPT‐4o, 0.764 for DeepSeek‐R, and 0.765 for Grok‐2 (80% accuracy for each), followed by 0.729 for Claude 3.5 (77% accuracy) and 0.611 for Gemini (68.4% accuracy). The lowest calibration error was found in ChatGPT‐4o (19.2%) and DeepSeek‐R1 scored the highest for readability. In understandability analysis, Claude 3.5 had the highest rating compared to others.Conclusion: Chatbots demonstrated various powers across different tasks. DeepSeek‐R1, despite being just released, showed promising results in medical applications. These findings highlight the need for further optimisation to better understand the applications of chatbots in urology.
- 31 July 2025
- Published by Wiley in BJU International
Chatbots in urology: accuracy, calibration, and comprehensibility; is DeepSeek taking over the throne?
Objective: To evaluate widely used chatbots’ accuracy, calibration error, readability, and understandability with objective measurements by 35 questions derived from urology in‐service examinations, as the integration of large language models (LLMs) into healthcare has gained increasing attention, raising questions about their applications and limitations.Materials and Methods: A total of 35 European Board of Urology questions were asked to five LLMs with a standardised prompt that was systematically designed and used across all models: ChatGPT‐4o, DeepSeek‐R1, Gemini, Grok‐2, and Claude 3.5. Accuracy was calculated by Cohen's kappa for all models. Readability was assessed by Flesch Reading Ease, Gunning Fog, Coleman–Liau, Simple Measure of Gobbledygook, and Automated Readability Index, while understandability was determined by scores of residents’ ratings by a Likert scale.Results: The models and answer key were in substantial agreement with a Fleiss’ kappa of 0.701, and Cronbach's alpha of 0.914. For accuracy, Cohen's kappa was 0.767 for ChatGPT‐4o, 0.764 for DeepSeek‐R, and 0.765 for Grok‐2 (80% accuracy for each), followed by 0.729 for Claude 3.5 (77% accuracy) and 0.611 for Gemini (68.4% accuracy). The lowest calibration error was found in ChatGPT‐4o (19.2%) and DeepSeek‐R1 scored the highest for readability. In understandability analysis, Claude 3.5 had the highest rating compared to others.Conclusion: Chatbots demonstrated various powers across different tasks. DeepSeek‐R1, despite being just released, showed promising results in medical applications. These findings highlight the need for further optimisation to better understand the applications of chatbots in urology.
- Open Access
- 13 June 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (5) , 404-411
Astaxanthin mitigates radiation-induced erectile dysfunction: protective effects on corpus cavernosum in a rat model
The objective of this study was to evaluate the effects of ionizing radiation (iR) on corpus cavernosum and the potential of astaxanthin (AST) in preventing radiation-induced erectile dysfunction (RiED). Male Wistar Albino rats (10–12 week, 250–300 g) were divided-into four groups: sham (SH, n = 8), radiotherapy (RT, n = 8), vehicle-administered (olive oil (OO); RT + OO, n = 12), and astaxanthin (RT + AST, n = 12). The RT-group received 12-Gy prostate-targeted iR. The vehicle-administered (OO) group received iR with daily 1 ml OO via oral gavage, while the AST-group received iR with 50 mg/kg AST dissolved in OO. After the treatment-period (12-week), intracavernosal pressure to mean arterial pressure (ICP/MAP) ratios in the RT [0.28(0.14–0.65)] and OO groups [0.26(0.19–0.64)] were significantly lower than in the SH [0.6(0.43–0.72)] and AST [0.53(0.35–0.64)] groups ( p < 0.05). iR caused narrowing of the cavernous sinusoids (RT:95.38 (84.62–110.05) vs SH:132.33 (113.27–155.86), AST:124.44 (112.11–131.97) µm, p < 0.001). Alpha smooth muscle actin (SH:165 (136.25–188.75) vs RT:100 (87.5–112.5), AST:137.5 (107.5–155), p < 0.001), endothelial nitric-oxide synthase (NOS) (SH:127.5 (115–167.5) vs RT:92.5 (81.25–98.75), AST:115 (86.25–128.75), p = 0.002) and neuronal NOS (SH:152.5 (133.75–163.75) vs RT:95 (81.25–103.75), AST:135 (125–140), p < 0.001) were diminished in the RT-group and preserved in the AST-group according to immunohistochemical scoring. Biochemical measurements of the corpus cavernosum revealed that the level of cGMP was significantly higher (93.15 (71.22–103.38) vs 70.8 (65–72.35) pmol/ml) in the AST-group, while lipid peroxidation was significantly higher (32.38 (29.07–36.98) vs 20.14 (17.85–21.04) nmol.mda/g) in the RT-group ( p = 0.004, p < 0.001). This trial showed that AST preserved ICP/MAP values and histopathological-biochemical parameters after exposure to iR.
- 13 June 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (5) , 404-411
Open AccessAstaxanthin mitigates radiation-induced erectile dysfunction: protective effects on corpus cavernosum in a rat model
The objective of this study was to evaluate the effects of ionizing radiation (iR) on corpus cavernosum and the potential of astaxanthin (AST) in preventing radiation-induced erectile dysfunction (RiED). Male Wistar Albino rats (10–12 week, 250–300 g) were divided-into four groups: sham (SH, n = 8), radiotherapy (RT, n = 8), vehicle-administered (olive oil (OO); RT + OO, n = 12), and astaxanthin (RT + AST, n = 12). The RT-group received 12-Gy prostate-targeted iR. The vehicle-administered (OO) group received iR with daily 1 ml OO via oral gavage, while the AST-group received iR with 50 mg/kg AST dissolved in OO. After the treatment-period (12-week), intracavernosal pressure to mean arterial pressure (ICP/MAP) ratios in the RT [0.28(0.14–0.65)] and OO groups [0.26(0.19–0.64)] were significantly lower than in the SH [0.6(0.43–0.72)] and AST [0.53(0.35–0.64)] groups ( p < 0.05). iR caused narrowing of the cavernous sinusoids (RT:95.38 (84.62–110.05) vs SH:132.33 (113.27–155.86), AST:124.44 (112.11–131.97) µm, p < 0.001). Alpha smooth muscle actin (SH:165 (136.25–188.75) vs RT:100 (87.5–112.5), AST:137.5 (107.5–155), p < 0.001), endothelial nitric-oxide synthase (NOS) (SH:127.5 (115–167.5) vs RT:92.5 (81.25–98.75), AST:115 (86.25–128.75), p = 0.002) and neuronal NOS (SH:152.5 (133.75–163.75) vs RT:95 (81.25–103.75), AST:135 (125–140), p < 0.001) were diminished in the RT-group and preserved in the AST-group according to immunohistochemical scoring. Biochemical measurements of the corpus cavernosum revealed that the level of cGMP was significantly higher (93.15 (71.22–103.38) vs 70.8 (65–72.35) pmol/ml) in the AST-group, while lipid peroxidation was significantly higher (32.38 (29.07–36.98) vs 20.14 (17.85–21.04) nmol.mda/g) in the RT-group ( p = 0.004, p < 0.001). This trial showed that AST preserved ICP/MAP values and histopathological-biochemical parameters after exposure to iR.